| Application no. and date | 18819365.0 (espacenet) (Federated) (European Patent Register), 20181211 | | Patent/reg. no. and date | DK/EP 3585382, 20210714 | | Publication date | 20200101 | | Priority no. and date | GB 201720622, 20171211, GB 201802354, 20180213 | | EP pub. no. and date |
EP 3585382 20200101 | | Effective date | | | Applicant/owner | Mereo BioPharma 1 Limited, 1 Cavendish Place
London, Greater London W1G 0QF, GB | | Applicant ref. no. | P77278DK01 | | Inventor | MACKINNON, Alastair, Mereo BioPharma Group plc 4th Floor,
1 Cavendish Place
London Greater London W1G 0QF, GB,
PARKIN, Jacqueline, Mereo BioPharma Group plc 4th Floor,
1 Cavendish Place
London Greater London W1G 0QF, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , A61P 11/00 (2006.01) | | Title | ANVENDELSE AF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMID I BEHANDLINGEN AF AKUTTE FORVÆRRINGER AF KRONISK OBSTRUKTIV LUNGESYGDOM | | Int. application no. | GB2018053590 | | Int. publication no. | WO2019116021 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
